Holen Sie sich die Stockscreener-App
9.65
0.10%
-0.010
Schlusskurs vom Vortag:
$9.66
Offen:
$9.99
24-Stunden-Volumen:
1.11M
Relative Volume:
1.32
Marktkapitalisierung:
$927.46M
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-17.13
EPS:
-0.5635
Netto-Cashflow:
-
1W Leistung:
-0.21%
1M Leistung:
-18.50%
6M Leistung:
+0.00%
1J Leistung:
+0.00%
1-Tages-Spanne:
$9.65
$10.15
1-Wochen-Bereich:
$9.03
$10.35
52-Wochen-Spanne:
$7.23
$19.45
Lumexa Imaging Holdings Inc Stock (LMRI) Company Profile
Firmenname
Lumexa Imaging Holdings Inc
Sektor
Branche
Telefon
704-334-7830
Adresse
4200 SIX FORKS ROAD, RALEIGH
Compare LMRI vs ABT, SYK, MDT, BSX, EW
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
LMRI
Lumexa Imaging Holdings Inc
|
9.65 | 928.42M | 0 | 0 | 0 | -0.5635 |
ABT
Abbott Laboratories
|
96.00 | 168.22B | 45.13B | 6.28B | 7.40B | 3.5895 |
SYK
Stryker Corp
|
338.34 | 131.49B | 25.12B | 3.25B | 4.28B | 8.3984 |
MDT
Medtronic Plc
|
85.00 | 110.66B | 35.48B | 4.64B | 5.41B | 3.582 |
BSX
Boston Scientific Corp
|
60.99 | 95.46B | 20.08B | 2.89B | 3.66B | 1.9391 |
EW
Edwards Lifesciences Corp
|
81.44 | 46.69B | 6.07B | 1.06B | 1.34B | 1.8063 |
Lumexa Imaging Holdings Inc Stock (LMRI) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-02-09 | Hochstufung | Raymond James | Outperform → Strong Buy |
| 2026-01-05 | Eingeleitet | Barclays | Overweight |
| 2026-01-05 | Eingeleitet | Deutsche Bank | Buy |
| 2026-01-05 | Eingeleitet | JP Morgan | Overweight |
| 2026-01-05 | Eingeleitet | Jefferies | Buy |
| 2026-01-05 | Eingeleitet | Leerink Partners | Outperform |
| 2026-01-05 | Eingeleitet | Raymond James | Outperform |
| 2026-01-05 | Eingeleitet | Wells Fargo | Overweight |
| 2026-01-05 | Eingeleitet | William Blair | Outperform |
Alle ansehen
Lumexa Imaging Holdings Inc Aktie (LMRI) Neueste Nachrichten
Lumexa Imaging names Kyle Lynch as chief growth officer By Investing.com - Investing.com Canada
Lumexa Imaging Appoints Kyle Lynch as Chief Growth Officer - marketscreener.com
Top Lumexa Imaging (LMRI) Competitors 2026 - MarketBeat
Jefferies reiterates Lumexa Imaging stock rating on demand outlook By Investing.com - Investing.com Canada
LMRI Maintains Overweight by Barclays -- Price Target Lowered to $15.00 - GuruFocus
Lumexa Imaging price target lowered to $15 from $23 at Barclays - TipRanks
Analysts’ Top Technology Picks: IonQ (IONQ), Lumexa Imaging Holdings, Inc. (LMRI) - The Globe and Mail
Lumexa Imaging reiterates 2026 guidance during site visit By Investing.com - Investing.com Canada
Lumexa Imaging reiterates 2026 guidance during site visit - Investing.com
Lumexa Imaging Holdings IncReiterates full year 2026 guidance on April 8, 2026SEC filing - marketscreener.com
Lumexa Imaging Reaffirms Full-Year 2026 Financial Guidance - TipRanks
Lumexa Imaging reiterates full-year 2026 guidance after site visit - TradingView — Track All Markets
Lumexa Imaging (LMRI) reiterates previously disclosed full-year 2026 guidance - Stock Titan
Should I buy Lumexa Imaging Holdings, Inc. (LMRI) - Zacks Investment Research
Lumexa Imaging Holdings, Inc. Common Stock Stock Forecast Summary - Meyka
Lumexa Imaging Earnings Call Highlights Growth Momentum - TipRanks
Earnings Call Summary | Lumexa Imaging(LMRI.US) Q4 2025 Earnings Conference - 富途牛牛
Maintaining Buy on LMRI: Market Overdiscounts Consolidated Centers, Creating Upside to $17 Target - TipRanks
Raymond James cuts Lumexa Imaging stock price target on soft outlook - Investing.com Canada
Lumexa Imaging price target lowered to $17 from $23 at Raymond James - TipRanks
Jefferies reiterates Lumexa Imaging stock rating citing growth outlook By Investing.com - Investing.com Canada
LMRI SEC FilingsLumexa Imaging Holdings 10-K, 10-Q, 8-K Forms - Stock Titan
Lumexa Imaging (NASDAQ: LMRI) hits $1.023B revenue and raises $427M IPO - Stock Titan
Lumexa Imaging: Clearer Growth Path Ahead (NASDAQ:LMRI) - Seeking Alpha
LMRI Technical Analysis & Stock Price Forecast - Intellectia AI
Analysts Offer Insights on Technology Companies: Intuit (INTU), Rubrik, Inc. Class A (RBRK) and Lumexa Imaging Holdings, Inc. (LMRI) - theglobeandmail.com
Analysts Offer Insights on Technology Companies: Lumexa Imaging Holdings, Inc. (LMRI), Adobe (ADBE) and Blaize Holdings (BZAI) - The Globe and Mail
Lumexa Imaging Reports Strong Q4 and Full Year 2025 Results, Reiterates 2026 Guidance and Outlines Growth Strategy - Minichart
Lumexa Imaging Posts Strong Q4 Growth, Reaffirms 2026 Outlook - TipRanks
Lumexa Imaging Holdings, Inc. Shareholders Are Encouraged - GlobeNewswire
Lumexa Imaging Holdings, Inc. Shareholders Are Encouraged to Reach Out to Johnson Fistel for More Information About Potentially Recovering Their Losses - GlobeNewswire Inc.
Earnings call transcript: Lumexa Imaging Q4 2025 reveals unexpected EPS miss - Investing.com Canada
Leerink reiterates Outperform on Lumexa Imaging stock at $23 By Investing.com - Investing.com Canada
Leerink reiterates Outperform on Lumexa Imaging stock at $23 - Investing.com
Lumexa Imaging Holdings, Inc. Reports Earnings Results for the Full Year Ended December 31, 2025 - marketscreener.com
Lumexa Imaging Announces Fourth Quarter and Full Year 2025 Results, Reiterates Full Year 2026 Guidance - Bitget
Lumexa Imaging Holdings Inc has released its financial guidance for 2026, expecting adjusted EBITDA to be between $234 million and $242 million. - Bitget
Lumexa Imaging Q4 Loss Widens, Revenue Rises; Issues 2026 Adjusted EPS Guidance - MarketScreener
Lumexa: Q4 Earnings Snapshot - MarketScreener
Lumexa Imaging (Nasdaq: LMRI) grows 2025 revenue, cuts debt and loss - Stock Titan
Earnings Flash (LMRI) Lumexa Imaging Posts Preliminary Q4 Loss $0.38 a Share - marketscreener.com
Earnings Flash (LMRI) Lumexa Imaging Holdings, Inc. Reports Q4 Revenue $267.7M, vs. FactSet Est of $261.2M - MarketScreener
Lumexa says new imaging centers and scan demand lifted EBITDA 19% - Stock Titan
Lumexa Imaging Q4 2025 Earnings Call Transcript - MarketBeat
Raymond James reiterates Strong Buy on Lumexa Imaging stock - Investing.com UK
Raymond James reiterates Strong Buy on Lumexa Imaging stock By Investing.com - Investing.com India
Finanzdaten der Lumexa Imaging Holdings Inc-Aktie (LMRI)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.74%
1.72%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):